Skip to main content
. 2019 Sep 19;18(5):5197–5204. doi: 10.3892/ol.2019.10892

Figure 2.

Figure 2.

Serum DLX6-AS1 is highly expressed in samples from patients with NSCLC and associated with clinicopathological characteristics. (A) Serum level of DLX6-AS1 was measured by reverse transcription-quantitative PCR in patients with NSCLC and healthy donors. (B) Associations between the serum DLX6-AS1 expression and TNM stage of patients with NSCLC. (C) Associations between the serum DLX6-AS1 expression and lymph node metastasis of patients with NSCLC. (D) Associations between the serum DLX6-AS1 expression and tumor differentiation of patients with NSCLC. Data were analyzed using Student's t-test. *P<0.05 and ***P<0.001. 18sRNA, 18S ribosomal RNA; DLX6-AS1, distal-less homeobox 6 antisense RNA 1; NSCLC, non-small cell lung cancer.